Works matching AU Balusson, Frédéric


Results: 24
    1
    2
    3
    4
    5

    Use of 5α‐reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population‐based study.

    Published in:
    BJU International, 2019, v. 123, n. 2, p. 293, doi. 10.1111/bju.14495
    By:
    • Scailteux, Lucie‐Marie;
    • Rioux‐Leclercq, Nathalie;
    • Vincendeau, Sébastien;
    • Balusson, Frédéric;
    • Nowak, Emmanuel;
    • Oger, Emmanuel;
    • Doucet, M;
    • Broyer‐Petit, Hainry;
    • Beyls‐Noel;
    • Coeugnet;
    • Girardot;
    • Golaire;
    • Tisseau;
    • Hogenhuis;
    • Perrot;
    • Moreau;
    • Staroz;
    • Tas, M;
    • Saout, M;
    • Politis, M
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Sleep Apnea Specific Hypoxic Burden, Symptom Subtypes and Risk of Cardiovascular Events and All-Cause Mortality.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 1, p. E1, doi. 10.1164/rccm.202105-1274oc
    By:
    • Trzepizur, Wojciech;
    • Ganem, Timothée;
    • Balusson, Frédéric;
    • Feuilloy, Mathieu;
    • Girault, Jean-Marc;
    • Meslier, Nicole;
    • Oger, Emmanuel;
    • Paris, Audrey;
    • Pigeanne, Thierry;
    • Racineux, Jean-Louis;
    • Sabil, AbdelKebir;
    • Gervès-Pinquié, Chloé;
    • Gagnadoux, Frédéric
    Publication type:
    Article
    15
    16
    17

    Real‐world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases.

    Published in:
    Fundamental & Clinical Pharmacology, 2019, v. 33, n. 4, p. 479, doi. 10.1111/fcp.12454
    By:
    • George, Gincy;
    • Scailteux, Lucie‐Marie;
    • Garmo, Hans;
    • Balusson, Frédéric;
    • Cardwell, Christopher;
    • Coster, Greet De;
    • Schutter, Harlinde De;
    • Kuiper, Josephina G.;
    • McMenamin, Úna;
    • Verbeeck, Julie;
    • Van Hemelrijck, Mieke
    Publication type:
    Article
    18
    19

    Rationale and design of the CANARI study: a case–control study investigating the association between prostate cancer and 5‐alpha‐reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France

    Published in:
    Fundamental & Clinical Pharmacology, 2018, v. 32, n. 1, p. 120, doi. 10.1111/fcp.12320
    By:
    • Scailteux, Lucie‐Marie;
    • Balusson, Frédéric;
    • Vincendeau, Sébastien;
    • Rioux‐Leclercq, Nathalie;
    • Nowak, Emmanuel
    Publication type:
    Article
    20
    21
    22
    23
    24

    Overall Survival Among Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer Under Abiraterone Versus Enzalutamide: A Direct Comparison Based on a 2014–2018 French Population Study (the SPEAR Cohort).

    Published in:
    American Journal of Epidemiology, 2021, v. 190, n. 3, p. 413, doi. 10.1093/aje/kwaa190
    By:
    • Scailteux, Lucie-Marie;
    • Campillo-Gimenez, Boris;
    • Kerbrat, Sandrine;
    • Despas, Fabien;
    • Mathieu, Romain;
    • Vincendeau, Sébastien;
    • Balusson, Frédéric;
    • Happe, André;
    • Nowak, Emmanuel;
    • Oger, Emmanuel
    Publication type:
    Article